0000819050-22-000049.txt : 20220509 0000819050-22-000049.hdr.sgml : 20220509 20220509161750 ACCESSION NUMBER: 0000819050-22-000049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220505 FILED AS OF DATE: 20220509 DATE AS OF CHANGE: 20220509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McAvoy David R. CENTRAL INDEX KEY: 0001758842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21088 FILM NUMBER: 22905214 MAIL ADDRESS: STREET 1: C/O ENDOCYTE, INC., 3000 KENT AVENUE STREET 2: SUITE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Brickell Biotech, Inc. CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (720) 505-4755 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: VICAL INC DATE OF NAME CHANGE: 19940211 4 1 wf-form4_165212745351640.xml FORM 4 X0306 4 2022-05-05 0 0000819050 Brickell Biotech, Inc. BBI 0001758842 McAvoy David R. C/O BRICKELL BIOTECH, INC. 5777 CENTRAL AVENUE, SUITE 102 BOULDER CO 80301 0 1 0 0 General Counsel and CCO Stock Option (right to buy) 0.26 2022-05-05 4 A 0 300000 0 A 2023-05-05 2032-05-05 Common Stock 300000.0 300000 D The stock options will vest 25% on the first anniversary of the grant date, and the remainder will vest in equal monthly installments over the following three years. /s/ Christine G. Long, Attorney-in-Fact for David R. McAvoy (power of attorney previously filed) 2022-05-09